Dr Marisa Flook is a Volunteer Writer at BioNews, having originally joined under the auspices of its writing scheme. She is currently working as a research engagement officer at Blood Cancer UK. Previously, Marisa was a postdoctoral researcher in Dr Mike Bowl's group at University College London Ear Institute, where she studied hearing loss genetics. Marisa completed her PhD in biomedicine at the University of Granada, Spain, focusing her research on the immunological background of Meniere's disease. She studied anatomical pathology, cytology and thanatology at the School of Health Polytechnic of Porto, Portugal. Additionally, she holds an MSc in molecular biology and genetics from the University of Lisbon, Portugal.
A new genome editing method allows long DNA fragments to be integrated into precise positions within the genome of cells...
An 11-year-old girl has become the first UK patient to receive an experimental gene therapy for an inherited eye disorder...
An anti-ageing gene therapy not approved by the US Food and Drug Administration is set to be offered by an American company at overseas clinics outside of US jurisdiction...
A child born with a congenital retinal disorder has had her sight restoredby an NHS-funded gene therapy...
Two genetic variants affect the response to glucagon-like peptide 1 (GLP-1) receptor agonists drugs, according to a new large-scale study by the 23andMe Research Institute...
After reanalysing decades of twin data, scientists now estimate that genetics plays a greater role in lifespan than was previously thought...
CRISPR-based genome editing has been used to overcome chemotherapy resistance in lung tumours by disabling a tumour-specific mutation...
Extremely advanced ageing and poor health are not intrinsically linked, according to a study of the longest-lived supercentenarian...
A gene variant has been shown to have different effects on patients based on their genetic sex...
A new type of CAR-T immunotherapy that targets aggressive T-cell blood cancer shows high remission rates and manageable side effects, according to the results of an international clinical trial...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
